List of Schedule V controlled substances (U.S.)

List of Schedule V Controlled Substances (U.S.)

In the United States, the Controlled Substances Act (CSA) of 1970 regulates the manufacture, importation, possession, use, and distribution of certain substances. The act categorizes drugs, substances, and certain chemicals used to make drugs into five distinct categories or schedules depending upon the drug’s acceptable medical use and the drug’s abuse or dependency potential. Schedule V controlled substances are defined as drugs with a lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. These are generally used for antitussive, antidiarrheal, and analgesic purposes.

List of Schedule V Controlled Substances

The following is a non-exhaustive list of substances that have been classified as Schedule V controlled substances by the Drug Enforcement Administration (DEA) in the United States:

• Codeine preparations - Containing not more than 200 milligrams of codeine per 100 milliliters or per 100 grams
• Diphenoxylate and Atropine - Tablets containing not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit
• Pregabalin - A medication used to treat epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder
• Lacosamide - An anticonvulsant used to treat partial-onset seizures and diabetic neuropathic pain
• Ezogabine - An anticonvulsant used to treat partial-onset seizures

Regulation and Usage

Schedule V drugs are considered to have a lower potential for abuse relative to substances listed in Schedule IV and consist of preparations containing limited quantities of certain narcotics. These substances are used for antitussive (cough suppression), antidiarrheal, and analgesic (pain relief) purposes. Despite their lower potential for abuse, these drugs are still regulated and require a prescription for use. Pharmacists may sell these substances, but there are restrictions, including record-keeping requirements and limits on the amounts that may be sold to an individual.

Legal Implications

Possession, distribution, or manufacturing of Schedule V substances without proper authorization can lead to legal penalties. However, the penalties are generally less severe than for drugs classified under Schedules I through IV. It is important for individuals and healthcare providers to be aware of the regulations governing the use of these substances to ensure compliance with federal law.

See Also

• Controlled Substances Act
• Drug Enforcement Administration
• Drug policy of the United States
• Pharmacology
• Prescription drug